Cadmium (Cd) is a carcinogenic heavy metal which is implicated in breast cancer development. While the mechanisms of Cd-induced breast cancer initiation and promotion have been studied, the molecular processes involved in breast cancer progression remain to be investigated. The purpose of the present study was to evaluate the influence of Cd on metastasis-associated phenotypes, such as cell adhesion, migration, and invasion in triplenegative breast cancer cells. Treatment of MDA-MB-231 cells with 1 μM Cd increased cell spreading and cell migration. This was associated with the activation of integrin β1, FAK, Src, and Rac1. Treatment with Cd also inhibited GSK3β activity and induced T-cell factor/lymphoid enhancer factor (TCF/LEF) transcription, indicating the involvement of β-catenin signaling. Furthermore, treatment with 3 μM Cd for 4 weeks increased the expression of β-catenin and enhanced TCF/LEF-mediated transcription. Furthermore, enhanced expressions of integrins α5 and β1, paxillin, and vimentin indicated that prolonged Cd treatment reorganized the cytoskeleton, which aided malignancy, as evidenced by enhanced matrix metalloprotease 2/9 (MMP2/9) secretion and cell invasion. Prolonged Cd treatment also caused an increase in cell growth. Together, these results indicate that Cd alters key signaling processes involved in the regulation of cytoskeleton to enhance cancer cell migration, invasion, adhesion, and proliferation.
Introduction
Cadmium (Cd) is a toxic heavy metal and exposure to this metal has been associated with a variety of cancers, including breast cancer (Stayner et al., 1992; Il'yasova and Schwartz, 2005; Sahmoun et al., 2005; Julin et al., 2012a Julin et al., , 2012b . Studies in mice and rats have confirmed that Cd treatment results in the development of lung, breast, and bladder cancer (Takenaka et al., 1983; Shiraishi et al., 1994; Johnson et al., 2003; Schrauzer, 2008; Davis et al., 2013) . The International Agency for Research on Cancer has categorized Cd as a Group 1B carcinogen.
Carcinogenesis is a continuous process comprised of initiation, promotion, and progression. Several studies indicate that Cd promotes breast cancer cell growth, with some suggesting that it also promotes metastasis (Yang et al., 2004; Benbrahim-Tallaa et al., 2009; Siewit et al., 2010) . Promotion of cell growth by Cd is described as a xenoestrogenic effect (Siewit et al., 2010; Ponce et al., 2013; involving membrane receptors (Yu et al., 2010; Wei et al., 2015) . Waalkes et al. (2000) reported that chronic Cd treatment increased metastatic potential of sc-injected sarcomas in rats. Metastasis is a multi-step process that includes dissemination, migration, intravasation, extravasation, and colonization to form secondary tumors. Specific mechanisms by which Cd may promote these steps in breast cancer cells are poorly understood. Ponce et al. (2015) reported that Cd interferes with cell-cell interaction by disrupting E-cadherin, enhancing the ability of breast cancer cells to disseminate from the primary tumor.
After disseminating from primary tumors, metastatic breast cancer cells enter a prolonged period of latency before forming secondary tumors. The rate-limiting steps seem to be extravasation and cell proliferation (Luzzi et al., 1998) . During extravasation, metastatic cancer cells migrate through endothelial barriers and settle in new microenvironments via cell adhesion molecules (Felding-Habermann et al., 2001 ). An important feature in metastatic cell movement is alteration of cellular microfilament dynamics and extracellular matrix (ECM) remodeling. Integrins adhere to ECM proteins and alter cytoskeletal dynamics. FAKSrc complex transduces integrin signaling to downstream Rac/Rho, which initiates assembly of microfilaments, leading to cell adhesion and migration (Mitra and Schlaepfer, 2006) . Crosstalk with PI3K and MAPK also promotes cell survival and proliferation (Giancotti and Ruoslahti, 1999) . In lung epithelial cells, 0.5-1 μM Cd stimulated actin filament formation (Go et al., 2013) . Also, Baroni et al. (2015) reported Toxicology and Applied Pharmacology 328 (2017) [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] that 10 μM Cd increased integrin β1 and β5 gene expression and directly affected the production of ECM proteins in human bronchial epithelial cells. Accordingly, it seems reasonable to hypothesize that Cd may affect metastasized breast cancer cell adhesion through alterations in integrin activation.
Colonization at metastasized sites requires cells to proliferate to counterbalance cell death. Activation of the Wnt/β-catenin pathway, that normally regulates cell proliferation during embryonic development, has been implicated in tumorigenesis in colon cancer, leukemia, and breast cancer (Reya and Clevers, 2005) . The Wnt pathway is initiated after Wnt ligands bind to Frizzled and Lrp 5/6 receptors. Receptor occupancy leads to accumulation of an important downstream signaling protein, β-catenin. GSK3β-mediated phosphorylation translocates β-catenin into the nucleus. There, it forms co-transcriptional activators with TCF/ LEF, driving transcription of many oncogenes (Eastman and Grosschedl, 1999) . Chakraborty et al. (2010b) reported that chronic treatment of mice resulted in increased release of Wnt ligand and transcription of Wnt receptors. The same group (Chakraborty et al., 2010a ) also reported that Cd enhanced nuclear translocation of β-catenin in human renal epithelial cells, which triggered TCF/LEF-mediated transcription. In addition, in rat renal epithelial cells, Cd increased free β-catenin accumulation through disruption of cadherins (Edwards et al., 2013) . Based on these studies, it seems that Cd may stimulate secondary tumor growth through activation of Wnt/β-catenin-dependent pathways.
Cell migration and metastasis involve increased ECM interaction, activation of adhesion-related signaling, crosstalk with β-catenin and mitogenic signaling. Such effects have recently been reported in triplenegative MDA-MB-231 breast cancer cells exposed to ionizing radiation which is known to paradoxically stimulate metastatic cancer growth (Bouchard et al., 2016; Galarza et al., 2016) . Promotion of MDA-MB-231 cell migration also occurs following treatment with TNF-α (Wolczyk et al., 2016) . The purpose of the present study was to test the hypothesis that Cd exerts stimulatory effects on migration and invasion in breast cancer cells. Results presented here were derived mainly from the triple-negative MDA-MB-231 cells.
Materials and methods

Materials
DMEM and trypsin-versene were purchased from Lonza (Walkersville, MD). Fetal bovine serum (FBS) was purchased from Atlanta Biologicals (Flowery Branch, GA). CdCl 2 , PMSF and protease inhibitor were purchased from Sigma-Aldrich (Dallas, TX). Bis-acrylamide powder, BCA kit, protein ladder, and extracellular matrix components were purchased from Thermo-Fisher Scientific (Pittsburgh, PA). Phosphatase inhibitor cocktail tablets were purchased from Roche (Indianapolis, IN). Gelatin-zymogram gel, Laemmli buffer and blotting buffers were obtained from Bio-Rad (Hercules, CA). Phorbol 12-myristate 13-acetate (PMA) and diphenyleneiodonium chloride (DPI) were purchased from Cayman Chemical (Ann Arbor, Michigan). Active-integrin β1, GAPDH antibodies, integrins-linked kinase (ILK) inhibitor Cpd 22, Amicon centrifugal filter units (NMWL 10), slide chambers and Transwell inserts were purchased from EMD Millipore (Billerica, MA). Phosphor Rac1, α-actinin, phosphor-ERK 1/2 (Thr 202/Tyr 204), ERK, phosphor-Src (Tyr 416), Src, phosphor-FAK (Tyr 397) and FAK primary antibodies were from Cell Signaling Technology (Danvers, MA). CF5.5 goat anti-rabbit IgG was purchased from Santa Cruz Biotechnology (Dallas, TX). IRDye 680 goat anti-rabbit and goat anti-mouse IgG antibodies were purchased from Licor (Lincoln, NE). TOPFlash and pRL-TK plasmids were purchased from Addgene (Cambridge, MA). Genjet DNA transfection reagent was purchased from SignaGen Laboratories (Gaithersburg, MD). β-catenin siRNA (siGENOME Human CTNNB1 1499 -SMARTpool, catalog #M-003482-00-0005), nonsense siRNA (catalog #D-001206-01-05), transfection reagent, and RNase were from GE Healthcare Dharmacon (Chicago, IL). Nuclear Extract Kit was purchased from Active Motif (Carlsbad, CA). Cell Counting Kit-8 was purchased from Dojindo Molecular Technologies (Rockville, MD). Cultrex 3-D spheroid cell invasion assay kit was obtained from Trevigen (Gaithersburg, MD). E-PlateView 16-well plates were purchased from ACEA Biosciences (San Diego, CA). Dual-luciferase assay kit was from Promega (Madison, WI).
Cell lines and cell culture
Breast cancer derived triple-negative MDA-MB-231 cells and hormone-responsive MCF7 cells were obtained from the American Type Culture Collection (Manassas, VA). The cells were cultured in DMEM supplemented with 10% FBS and penicillin (100 U/mL)/streptomycin (100 U/mL). Cells were maintained in a humidified incubator (37°C) with 5% CO 2 .
Wound healing assay
The wound healing assay was performed in a 12-well plate. MDA-MB-231 cells were seeded in three replicates and cultured in DMEM with 10% FBS. Wounds were generated by scratching the 90% confluent cell monolayer with a 1-20 μL pipet tip. The unattached cells were washed away with PBS and attached cells were treated with 0.5-1 μM Cd in 10% FBS-supplemented DMEM. Images of the wounds were acquired every 24 h under phase contrast microscopy. The scratch area was measured using MRI Wound Healing Tool in ImageJ software and relative scratch closure was calculated based on the change in the scratch area at time zero.
Electrical impedance assay
MDA-MB-231 cells were seeded at a density of 8000 cells/well in EPlateView 16 plates and cultured in DMEM with 10% FBS. The bottom of the plate was covered with gold microelectrode sensors that generated an electric field when a low voltage (b20 mV) was applied between electrodes. Cells in the logarithmic growth phase were treated with DMEM containing 1-10 μM Cd, or 10 μM Cd and 0.5 μM DPI or 1 μM Cpd 22. Cell adhesion was monitored by using xCELLigence RTCA system at a sweeping interval of 15 s. Results were profiled and plotted by using the RTCA software.
Immunofluorescent staining
MDA-MB-231 cells were seeded in slide chambers and grown in DMEM with 10% FBS. After 24 h, the cells were treated with 1 or 3 μM Cd in DMEM for 3 h. For specimen preparation, cells were fixed by treatment with 4% paraformaldehyde in PBS for 15 min followed by permeation with 0.3% Triton X-100 in 1% BSA-supplemented PBS. Cells were then blocked in 5% BSA-supplemented PBS. Finally, the cells were incubated with primary antibody for α-actinin overnight. After washing with PBS for 5 min, three times, the cells were stained using secondary antibody, CF 5.5 goat anti-rabbit IgG. Nuclei were stained with DAPI. Images of the stained cells were captured with a Nikon NE2000 fluorescence microscope.
Western blot analysis
Whole cell lysates were prepared in RIPA buffer. Nuclear and cytoplasmic fraction samples were prepared using an Active Motif nuclear extraction kit. Protein concentration in lysates was determined using the BCA kit. Proteins were denatured by heating the lysate to 95°C in Laemmli buffer containing 5% β-mercaptoethanol. Samples requiring non-reduced proteins were prepared in Laemmli buffer without β-mercaptoethanol. Proteins in the samples were then separated by SDS-PAGE electrophoresis and transferred to nitrocellulose membranes. The membranes were incubated with 5% non-fat milk for 1 h followed by incubation with the primary antibody overnight. The membranes were rinsed for 5 min three times in PBS containing 0.5% Tween 20, and incubated with secondary antibody for 1 h, followed by three additional washings in PBS containing 0.5% Tween 20, before imaging. The membranes were scanned by an Odyssey Infrared Imager. The optical density of the bands was quantified by the Odyssey image analysis software.
Luciferase reporter assay
MDA-MB-231 cells were seeded in 96-well plates and cultured in DMEM with 10% FBS. After 24 h, the cells were transfected with pRL-TK (2 ng/well) and TOPFlash (50 ng/well) plasmids for 48 h. The cells were serum starved by incubating in blank medium overnight, prior to treatment with Cd for 8 h. Firefly and renilla luciferase activities were generated by using Promega Dual-Luciferase assay and measured in a Glomax luminometer. Relative luciferase activity was quantified as the ratio of firefly to renilla luciferase activities.
Transwell assay
Transwell compartments (8 μm pore size) were prepared and inserted in a 24-well plate. The membranes were coated with 2 μg/mL collagen, 2 μg/mL fibronectin, 8 μg/mL vitronectin, and 8 μg/mL laminin. Cells were seeded into upper chambers in DMEM supplemented with 10% FBS. After incubation for 48 h, cells in the upper chamber were carefully removed with a cotton swab. The cells remaining on the underside of the membranes were fixed in 70% ethanol for 10 min and then stained with 0.5% crystal violet solution. Membranes with stained cells were imaged using an EVOS microscope at scan mode. To quantify the number of cells that migrated to the lower chamber, crystal violet stained cells were de-stained in 20% methanol. Migrated cell numbers in control and Cd-treated groups were determined by the absorbance of de-staining solutions at 450 nm in a Spectromax microplate reader. The relative migration tendency of Cd-treated cells was quantified as the ratio of absorbance reading by the treated cells over that of the control cells.
Gel zymography analysis
Precast gelatin-zymogram SDS-polyacrylamide gels were co-polymerized with gelatin. Media from cultured cells were concentrated 10-fold by centrifuging in Amicon filter units at 4000g for 30 min before adding to non-denaturing loading buffer solution. Protein concentration of all samples was determined and normalized to the same level before loading the samples onto gels. Electrophoresis of gelatin-zymogram gels was performed at 100 V for 1 h. Gels were washed and incubated in renaturing buffer for 40 min and incubated in developing buffer overnight at 37°C. Then gels were stained with 0.1% Coomassie R-250 brilliant blue for 1 h and washed for 30 min until clear bands developed. Gelatinolytic activity (relative intensity of clear bands) of secreted MMP 9 and MMP 2 was quantified by densitometry analysis using the Odyssey image analysis software.
Cell proliferation assay
Untreated and 4-week Cd-treated MDA-MB-231 cells were harvested and seeded in a 96-well plate at a density of 10,000 cells/well in DMEM supplemented with 10% FBS. After 4 days, cell growth was measured by Cell-Counting Kit 8. Absorbance was read at 450 nm and relative cell growth of Cd-treated cells was compared to untreated control cells.
3D cell culture
A spheroid invasion assay was used to estimate cell invasiveness. The experiment was performed by using a Cultrex 3-D spheroid cell invasion assay kit. Control and 4-week Cd-treated cells were harvested and seeded at a density of 5000 cells/well in low-adhesive round-bottom 96-well plates. The cells were cultured in DMEM supplemented with 10% FBS and basal membrane extract. After 4 days, the cells assembled into a compact spheroid. At that point, Matrigel was added to each well to provide a solidified invasion matrix. The growth of spheroids was observed microscopically and imaged daily.
Transfection with siRNA
MDA-MB-231 cells were cultured in DMEM containing 10% FBS and transfected with 2 μL β-catenin siRNA (20 μM) and 2 μL transfection reagent for 48 h. Cells transfected with nonsense siRNA were used as negative control.
Data analysis
All experiments were repeated at least three times. Western blot and zymography data were analyzed and quantified by Odyssey imaging analysis software. One-way ANOVA was performed by Prism with Tukey's post hoc test on all data and p b 0.05 was considered statistically significant.
Results
Changes in cytoskeletal dynamics
The wound healing assay was employed to study cell migration. Scratches were created on cell monolayers and the cells were treated with 0.5 and 1 μM Cd to determine if Cd would cause the cells in the surrounding area to migrate and fill the gap created by the scratch. As shown in Fig. 1A , scratches in the Cd-treated cells appeared to heal quicker than in the untreated control cells. Quantitively, at both concentrations of Cd 75% of the scratched area healed in 48 h as compared to only 42% healing in the control cells. These results indicated that nontoxic concentration of Cd facilitated cell migration in the triple-negative MDA-MB-231 breast cancer cells.
Next, a real-time electrical impedance assay was employed to track cell spreading. Adding 1 or 3 μM Cd to attached cells caused a moderate increase in the cell spreading index that peaked between 6 and 8 h (Fig. 1B top) . Higher concentration of Cd caused an even greater increase (1.6-fold) in cell spreading as compared to the control cells. However, this concentration was cytotoxic and cells began to lift off with the passage of time. Addition of 0.5 μM ROS inhibitor, DPI delayed this effect (Fig. 1B bottom) . In contrast, the presence of 1 μM ILK inhibitor Cpd 22 completely abolished the Cd-induced cell spreading.
Cell migration and spreading in response to Cd treatment were also assessed by analyzing the level of a dynamic cytoskeletal construction indicator, α-actinin, which cross-links actin filaments (Otey et al., 1990) . Cells treated with Cd for 3 h exhibited longitudinal filamentous α-actinin staining (Fig. 1C) . Its spatial distribution indicated that Cd stimulated the buildup of cytoskeletal proteins for cell spreading and subsequently cell migration.
Activation of integrin and downstream signaling
Upon stimulation, integrin transduces adhesion signal to focal adhesion kinases, which is essential in assembly of actin filaments (Mitra and Schlaepfer, 2006) . The effect of Cd treatment on integrin activation and downstream kinases was examined by Western blot analyses in not only the triple negative MDA-MB-231 cells, but also in hormoneresponsive MCF7 cells. As shown in Fig. 2A, treatment with 1 or 3 μM Cd or 100 nM PMA (positive control) for 15 min to 1 h caused about 2-fold increase in active integrin β1 expression in both the MDA-MB 231 cells and the MCF7 cells. Cd-treated MDA-MB-231 cells also displayed similar increases in phosphorylation of Src (Tyr 416) and FAK (Tyr 397), which indicated activation of kinases at focal adhesion sites. Rac1 is a downstream target of focal adhesion kinase, and is involved with regulation of actin polymerization (Vial et al., 2003) . Here, 1 and 3 μM Cd significantly elevated Rac1 phosphorylation, which was associated with the appearance of filamentous α-actinin (Fig. 1C) . Additionally, ERK 1/2 signaling was activated by Cd treatment, presumably because of integrin pathway crosstalk with MAPK signaling (Vial et al., 2003) . The activation of integrin itself and downstream signal transduction indicated that integrin was involved in Cd-induced cell adhesion.
β-catenin signaling and expression
To examine activation of the Wnt/β-catenin pathway in Cd-treated breast cancer cells, the MDA-MB-231 cells were transfected with TOPFlash plasmids which contained repeated TCF/LEF sites upstream of the luciferase reporter. As depicted in Fig. 3A , treatment with 3 μM Cd for 1 h increased luciferase activity 1.8-fold in the transfected cells, suggesting increased TCF/LEF-mediated transcription. This was further confirmed by the observation that Cd treatment enhanced phosphorylation of GSK3β (Ser 9) 1.5-fold, thus resulting in a decrease in the activity of GSK3β (Fig. 3B) . To further examine that Cd stimulated the Wnt/ β-catenin pathway, the ILK inhibitor Cpd 22 was utilized in the TOPFlash luciferase reporter assay. As shown in Fig. 3C , Cpd 22 significantly curtailed the Cd-induced increase in luciferase activity. It is evident that the Wnt/β-catenin pathway was activated in response to Cd treatment. The results also suggest that integrin signaling is involved in Cd-induced TCF/LEF transcription.
Next, the levels of β-catenin were determined in whole cell lysate, cytosol and nuclear extract of MDA-MB-231 cells treated with 3 μM Cd for 4 week. Western blot analyses showed that prolonged Cd treatment led to a 2.9-fold increase in β-catenin level in the cell lysate, a 1.9-fold increase in both the cytosolic and nuclear fractions (Fig. 4A) . Accumulation of β-catenin generated a larger pool of co-activator for TCF/ LEF-mediated transcription. As shown in Fig. 4B , luciferase activity in the 4-week Cd-treated cells was significantly higher than in the untreated cells, indicating that the basal TCF/LEF-mediated transcriptional activity was elevated after prolonged Cd treatment. When these cells were treated with 1 μM Cd for 8 h, the TCF/LEF-mediated transcription activity was even greater (2.8-fold) in the Cd-treated cells as compared to the nontreated cells. Knockdown of β-catenin by siRNA eliminated TCF/LEFmediated transcriptional activity in both the untreated and 4-week Cdtreated cells. Thus, the activation of TCF/LEF-mediated transcription upon prolonged Cd-treatment was dependent on β-catenin expression.
Cytoskeleton reorganization upon prolonged Cd treatment
To study how prolonged Cd treatment affects the cytoskeleton, the MDA-MB-231 cells were treated with 3 μM Cd for 4 weeks and stained with vimentin. These cells exhibited different spatial distribution of intermediate filaments when compared to the control cells (Fig. 5A) . Further exploration revealed that Cd treatment increased the expression of not only vimentin but also of integrins α5 and β1, and paxillin by 5.3-, 2.1-, 6.3-, and 3-fold, respectively (Fig. 5B) . The increases in intermediate filaments, integrins, and scaffold proteins indicated that prolonged Cd treatment reorganized the cytoskeleton.
Increase in cell migration, invasion and proliferation upon prolonged cd treatment
Transwell assay and MMP secretion were used to assess cell migration and invasion. To evaluate the effect of Cd on cell proliferation, cell growth was compared between the Cd-treated and control cells. Furthermore, the spheroid invasion assay was used to comprehensively examine cell invasion and proliferation. Microscopic pictures of the underside of Transwell membrane inserts showed that a greater number of Cd-treated cells migrated through the membrane toward the lower chamber than the untreated cells (Fig. 6A, top) . Quantified result indicated that 4 weeks of Cd treatment increased cell migration by 1.6-fold (Fig. 6A) . Activities of MMP 2 and 9 in cell culture medium were detected by in-gel zymography. As shown in Fig. 6B , the clear bands in the gel image indicated gelatinolytic activity of MMPs. Determined by molecular weight, the intensities of clear bands at 58 and 82 KDa represented activities of MMP 2 and 9, respectively. Together, the secretion of MMP 2 and 9 in Cd-treated cells was 3.4-fold higher than in the control cells.
To investigate whether 4 weeks of treatment with 3 μM Cd altered growth rate of MDA-MB-231 cells, the cells were harvested and cultured in the absence of Cd for 4 days. As shown in Fig. 7 , the pretreated cells exhibited 30% higher growth than the control cells.
Finally, the invasiveness of prolonged Cd-treated cells was evaluated in a 3D spheroid invasion assay. The Cd-treated cells exhibited a shady outer ring around the spheroid core appeared as early as on day-6 and became very pronounced on day-12 (arrow) (Fig. 8) . This ring was indicative of cell invasion into the surrounding Matrigel. In comparison, in control cells this ring became evident on day-12. Prolonged Cd treatment thus enhanced the migratory and invasive properties of breast cancer cells.
Discussion
Metastasis is a consecutive process which includes invasion into surrounding tissue, intravasation, extravasation, and colonization into secondary tumors (Nguyen et al., 2009) . Cell movement during this process is conducted through sequential activation of cell adhesion receptors which dynamically regulate cytoskeletal construction, leading to cell spreading and migration (Felding-Habermann et al., 2001) .
The results presented here suggest that Cd enhances metastasized triple-negative MDA-MB-231 breast cancer cell adhesion through integrin activation. Prolonged Cd treatment appears to stimulate malignancy, as evidenced by cytoskeleton reorganization and enhanced cell migration and invasion. Enhanced cell proliferation further facilitates metastasized cell growth. These are key indicators of metastatic changes consisting of cell migration to a new environment and growth into a secondary tumor. Moreover, cellular responses shortly after Cd treatment correlated with alterations in cells treated with Cd for 4 weeks. First, short-term Cd treatment led to integrin β1 activation, which preceded cell adhesion and cell migration. Prolonged Cd treatment also elevated integrin α5 and β1 expression and displayed markedly higher migration and invasion characteristics. Second, short-term Cd treatment activated β-catenin signaling. Prolonged Cd treatment also elevated expression of β-catenin, which rendered Cd-treated cells more responsive to the activation of Wnt/β-catenin signaling that contributes to cancer progression. Cd-induced cytoskeletal perturbation has been well studied in animal cells. Exposure to Cd leads to disassembly of microtubules in mouse 3T3 cells (Perrino and Chou, 1986) . In Cd-treated mouse mesangial cells, actin filaments become irregular and are lost because of disturbances in focal adhesion (Choong et al., 2013) . In contrast to these findings of cytoskeleton disruption upon Cd treatment, the results of the present study show that Cd treatment increases α-actinin, a binder of actin filaments polymerization, indicating active cytoskeleton buildup in the MDA-MB-231 cells (Fig. 1C) . Real-time tracking of cell attachment indicated that Cd treatment stimulated cell spreading. These results led to examination of the effects of Cd on receptors that regulate cell adhesion (Huttenlocher et al., 1996) . The present study is the first to report that Cd treatment induces cell adhesion through integrin activation (Fig. 2) . In this study, it was found that Cd, instead of disrupting focal adhesion as reported by Choong et al. (2013) , induced phosphorylation of focal adhesion kinases in breast cancer cells. This is a significant finding, because metastatic colonization at distant sites requires activation of integrin-mediated signaling (Reticker-Flynn et al., 2012) . Furthermore, increased expressions of intermediate filament (vimentin) and scaffold protein (paxillin) upon Cd treatment for 4 weeks (Fig. 5 ) provided evidence of cytoskeleton reorganization (Fife et al., 2014) . The elevation of vimentin increases focal contact size, which is critical for cancer cell movement (Tsuruta and Jones, 2003) .
Integrin plays an important role in tumor cell invasion and migration (Hood and Cheresh, 2002) . Disseminated tumor cells use integrin and protease to develop a mesenchymal-type migration pattern (Friedl and Wolf, 2003) . Several studies reported that integrin-associated MMPs became localized to cell-ECM sites when integrin was bound to the ECM (Mueller et al., 1999; Dumin et al., 2001 ). The present study observed in the Transwell assay an increase in cell migration in cells treated with Cd for 4 weeks (Fig. 6A) . Apparently, migrated cells had to degrade ECM on the membrane to enter the lower chamber because ECM blocks the membrane pores. The enhancement of MMP2/9 secretion ( Fig. 6B ) was parallel to integrin expression in Cd-treated breast cancer cells (Fig. 5B) . Increases in integrin and MMP levels are important for local tumor invasion because their interactions likely facilitate ECM degradation. Moreover, enhanced MMP secretion promotes the release of growth factors, including transforming growth factor β (TGFβ) and vascular endothelial growth factor (VEGF) (Bergers et al., 2000; Yu and Stamenkovic, 2000; Mu et al., 2002) . The released growth factors bind to membrane receptors which further stimulate cell proliferation and migration (Schenk et al., 2003) .
Canonical Wnt/β-catenin activation may facilitate carcinogenesis (Reya and Clevers, 2005) to the nucleus with subsequent triggering of TCF/LEF-mediated transcriptional machinery. In the present study, Cd activated TOPFlash luciferase reporter in the breast cancer cells (Fig. 3A) , similar to what has been reported in Cd-treated human kidney cells (Chakraborty et al., 2010a; Edwards et al., 2013) . In the kidney cells, the former investigators reported that Cd caused release of membrane-bound β-catenin to cytosol and nuclei due to disruption of E-cadherin-catenin at the cadherins junction complex. However, since the MDA-MB-231 cells do not express E-and N-cadherins, the related molecular events summarized in Fig. 9 are independent of the E-cadherin disruption.
β-catenin is an important co-activator of TCF/LEF-mediated transcription. It is caged by GSK3β for degradation. The result presented in Fig. 3B show that Cd inhibited GSK3β activity, resulting in β-catenin's escape from degradation. The free β-catenin translocated into the nucleus and increased TCF/LEF-mediated transcription (Fig. 3A) . Furthermore, prolonged Cd treatment elevated the expression of β-catenin (Fig. 4A) . Although the mechanism responsible for β-catenin accumulation remains unclear, some insight might be provided by the observation that upregulation of β-catenin rendered cells more responsive to Wnt/ β-catenin pathway stimulation and knockdown of β-catenin eliminated TCF/LEF-mediated luciferase activity in the TOPFlash assay (Fig. 4B) .
In triple-negative breast cancer cells, the integrin-dependent metastasis-associated phenotypes are accompanied by the upregulation of Wnt/β-catenin pathway (De et al., 2016) . The present study examined whether Cd could activate Wnt/β-catenin pathway without engaging integrins in the MDA-MB-231 cells. It was found that TCF/LEF-mediated transcription was diminished if cells were treated with Cd in lowadhesive plates (data not shown). This suggested that the involvement of integrin was important in Wnt/β-catenin activation. Furthermore, ILK inhibitor Cpd 22 suppressed Cd-induced activation of TCF/LEF-mediated transcription (Fig. 3C) . Since integrin signaling crosstalks with the Wnt/ β-catenin pathway at the GSK3β node (Burkhalter et al., 2011) , Cd likely activates ILK, which in turn inhibits GSK3β, resulting in β-catenininitiated TCF/LEF-mediated transcription. It was recently reported that integrin signaling affects Wnt/β-catenin pathway through Rac1 and Cdc42 activation (De et al., 2017) . It is plausible that Cd, by causing Rac1 activation, further facilitates β-catenin translocation into the nucleus.
Breast tumor cells that migrate to distant organs frequently enter a long latency period before developing into life-threatening metastasized breast cancer. During this process, environmental factors may affect tumor malignancy. Therefore, it is important to understand how environmental risks contribute to breast cancer progression. In this regard, the results reported here may provide some insight into this process. This study reports for the first time that an integrin-related mechanism is involved in the enhancement of breast cancer cell adhesion and migration by the environmental contaminant Cd. Furthermore, it shows that prolonged Cd treatment results in β-catenin accumulation, which renders breast cancer cells more sensitive to the activation of Wnt pathway. Based on the in vitro observation of Cd-induced integrin activation, it could be extrapolated that the metastasized cancer cells might be more likely to lodge at distant organs after Cd exposure in vivo. There is growing evidence that tumor spheroids represent tumor conditions in vivo. Spheroids exhibit several traits which 2D monolayer cultures lack, such as characteristic tumor morphology, cell-cell contact, and hypoxic centers. The results from this in vitro assay indicated that prolonged Cd treatment increases the migration and invasion ability of metastasized breast cancer cell, which may shorten the latency of breast cancer relapse.
In summary, Cd treatment activates integrin in triple-negative breast cancer cells, substantially increases their adhesion and migration. A schematic diagram of how Cd′s effects on integrin, GSK3β, and β- Gelatin zymograph of MMPs. Equal number of control and Cd-treated cells were cultured in serum-free medium for 2 days. The cell culture medium was collected and the supernatant after centrifugation was concentrated 10-fold prior to separation on gelatin-zymogram gels. MMP2/9 levels were visualized as clear bands at 58 and 82 kDa. Representative gel image is shown. Densities relative to those of the control cells are plotted as mean ± SEM (n = 3). *Significantly higher than the control cells (p b 0.05). Fig. 7 . Effect of prolonged Cd treatment on cell proliferation. The cells were cultured in 10% FBS-supplemented DMEM containing either no Cd or 3 μM Cd. After 4 weeks, the cells were harvested and seeded at equal densities in DMEM supplemented with 10% FBS, but no Cd, for 4 days. Cell proliferation was quantified using Cell Counting Kit-8. Absorbance at 450 nM relative to the control cells was plotted as mean ± SEM (n = 3). *Significantly higher than the control cells (p b 0.05).
catenin result in the activation of TCF/LEF-mediated transcription is presented in Fig. 9 . The results of this study contribute to a better understanding of how Cd stimulates triple-negative breast cancer cell progression and may be of value in designing better strategies for cancer interventions in the future. Fig. 8 . Effect of prolonged Cd treatment on cell invasion. The cells were cultured in DMEM supplemented with 3 μM Cd for 4 weeks. Control cells were cultured in medium alone. The cells were harvested and seeded in a round bottom 96-well plate at an equal density and grown in DMEM supplemented with basal membrane extract. Matrigel was added into each well after cells aggregated into spheroids. Cellular invasion of the spheroid was assessed by the appearance of a shady outer ring which was composed of cells invading into the Matrigel. Cd inhibits GSK3β, resulting in β-catenin's escape from degradation. Free β-catenin translocates into the nucleus and stimulates TCF/LEF-mediated oncogene transcription, which contributes to carcinogenesis.
